Primary study · included by 1 review

Health-related quality of life, fear of recurrence, and emotional distress in patients treated for thyroid cancer

Rogers 2017 · Rogers S.N., Mepani V., Jackson S., et al. · British Journal of Oral and Maxillofacial Surgery · 2017

Included by

Salivary and lacrimal disorders in patients treated with radioiodine for differentiated thyroid cancer.
Non-Cochrane · prognostic · 2026 · cited as Rogers 2017 · Reference list; Fig. 1-3
Outcome this study informsPooled effectEvidenceCertainty
Xerostomia (pooled prevalence)
Radioiodine (I131) therapy · within 2 months after RIT
Prevalence 0.60 [0.28, 0.85]3 studies · 1502 participantsGRADE not reported

1 including review in total.